Friday, October 7, 2011

Swine Flu and Big Business

 [This article was first published in the local press in August / September 2009]

For the year, we forecast sales of Tamiflu to reach ¥53.0 billion, up 531.0%, due to expected resumption of government stockpiling in FY2009 and the ongoing recovery of the prescription rate for seasonal influenza.
(p3) – Chugai Pharmaceutical Co. Ltd. Annual Report 2008 

The recent announcement that the shelf life of Tamiflu could be extended by another two years got me suspicious. If it could expire in 2011, why did the suppliers print 2009 on the box? Was there a sinister motive underlying this decision to print an earlier expiry date?